Vijaya Diagnostics approves Q3 results and management changes
after close1 source ↓written by the desknot a recommendation
- were granted
- 115,000 ESOPs
The board of Vijaya Diagnostics approved Q3 results, reporting significant changes in management, including new independent directors and C-suite appointments. Additionally, 115,000 ESOPs were granted, and the related party transaction policy was revised. These developments may enhance operational efficiency and governance standards.
• Q3 financials approved
• New directors appointed
• ESOP grant of 115,000
• RPT policy revised
Not investment advice. For informational purposes only.